Contact

What are you looking for?

Drug Product (DP)

Comprehensive testing for the drug product phase of production to ensure product compliance and product integrity.

Comprehensive testing for the drug product phase of production to ensure product compliance and product integrity.

At SGS, we offer a comprehensive testing service for the drug product (DP) phase of production. With over 25 years experience in GMP assays, we can support an array of essential tests to evaluate the quality, safety and efficacy of biologic products. We support all types of manufacturers to ensure confidence in the safety and effectiveness of your biologic product.

Services our biosafety team can offer

Identity:

  • Vector identity – Sanger sequencing

Qualification assay:

  • Vector particle concentration
  • Infectious particle titer
  • Infectivity/particle ratio

Batch release assay:

  • Bacterial endotoxin
  • Osmolality
  • pH
  • Extractable volume
  • Vector aggregates
  • Sterility
  • Appearance

Replication competent tests:

  • Replication competent adeno-associate virus (AAV)
  • Replication competent lentivirus (RCL)

Why work with SGS?

Contact us to learn more about drug product testing.

Related Services

More Services

News & Insights

  • SGS Supervise Gözetme Etüd Kontrol Servisleri A.Ş.

Bağlar Mah. Osmanpaşa Cad. No: 95, İş İstanbul Plaza A Girişi, Güneşli,

, 34209,

Istanbul,

Türkiye